Vascular fibrosis in atherosclerosis

Cardiovascular Pathology

Volumn 22, Issue 5, 2013, Pages 401-407

  Lan, Tao Hua ^a,b   Huang, Xiong Qing ^c   Tan, Hong Mei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Atherosclerosis; Fibrosis; Pathogenesis; Risk factors; Signal transduction

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CONNECTIVE TISSUE GROWTH FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MATRIX METALLOPROTEINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; ATHEROSCLEROSIS; DYSLIPIDEMIA; HUMAN; HYPERGLYCEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; VASCULAR FIBROSIS;

ATHEROSCLEROSIS; FIBROSIS; PATHOGENESIS; RISK FACTORS; SIGNAL TRANSDUCTION;

ATHEROSCLEROSIS; CONNECTIVE TISSUE GROWTH FACTOR; DYSLIPIDEMIAS; EXTRACELLULAR MATRIX; FIBROSIS; HUMANS; HYPERGLYCEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MATRIX METALLOPROTEINASES; MUSCLE, SMOOTH, VASCULAR; PPAR GAMMA; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84884149155     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2013.01.003     Document Type: Review

References (125)

1. R.M. Touyz Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II Exp Physiol 90 2005 449 455
2. N.A. Shirwany, and M.H. Zou Arterial stiffness: a brief review Acta Pharmacol Sin 31 2010 1267 1276
3. S. Katsuda, and T. Kaji Atherosclerosis and extracellular matrix J Atheroscler Thromb 10 2003 267 274
4. E. Arteaga-Solis, B. Gayraud, and F. Ramirez Elastic and collagenous networks in vascular diseases Cell Struct Funct 25 2000 69 72
5. M.P. Jacob Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions Biomed Pharmacother 57 2003 195 202
6. S.M. Arribas, A. Hinek, and M.C. Gonzalez Elastic fibres and vascular structure in hypertension Pharmacol Ther 111 2006 771 791
7. R.I. Bashey, R. Cox, J. McCann, and S.A. Jimenez Changes in collagen biosynthesis, types, and mechanics of aorta in hypertensive rats J Lab Clin Med 113 1989 604 611
8. J. Diez, C. Laviades, G. Mayor, M.J. Gil, and I. Monreal Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations Circulation 91 1995 1450 1456
9. J.E. Bishop, and G. Lindahl Regulation of cardiovascular collagen synthesis by mechanical load Cardiovasc Res 42 1999 27 44
10. C. Laviades, N. Varo, J. Fernandez, G. Mayor, M.J. Gil, and I. Monreal Abnormalities of the extracellular degradation of collagen type I in essential hypertension Circulation 98 1998 535 540
11. A.R. Pries, B. Reglin, and T.W. Secomb Remodeling of blood vessels: responses of diameter and wall thickness to hemodynamic and metabolic stimuli Hypertension 46 2005 725 731
12. R.M. Touyz Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II Curr Opin Nephrol Hypertens 14 2005 125 131
13. C. Savoia, D. Burger, N. Nishigaki, A. Montezano, and R.M. Touyz Angiotensin II and the vascular phenotype in hypertension Expert Rev Mol Med 13 2011 e11
14. M. Ruperez, O. Lorenzo, L.M. Blanco-Colio, V. Esteban, J. Egido, and M. Ruiz-Ortega Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis Circulation 108 2003 1499 1505
15. R. Sarzani, P. Brecher, and A.V. Chobanian Growth factor expression in aorta of normotensive and hypertensive rats J Clin Invest 83 1989 1404 1408
16. S.T. Ryan, V.E. Koteliansky, P.J. Gotwals, and V. Lindner Transforming growth factor-beta-dependent events in vascular remodeling following arterial injury J Vasc Res 40 2003 37 46
17. R.M. Touyz, and A.M. Briones Reactive oxygen species and vascular biology: implications in human hypertension Hypertens Res 34 2011 5 14
18. C.R. Ban, and S.M. Twigg Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers Vasc Health Risk Manag 4 2008 575 596
19. S.I. Andreea, C. Marieta, and D. Anca AGEs and glucose levels modulate type I and III procollagen mRNA synthesis in dermal fibroblasts cells culture Exp Diabetes Res 2008 2008 473603
20. W. Song, and A. Ergul Type-2 diabetes-induced changes in vascular extracellular matrix gene expression: relation to vessel size Cardiovasc Diabetol 5 2006 3
21. Z. Makita, R. Bucala, E.J. Rayfield, E.A. Friedman, A.M. Kaufman, and S.M. Korbet Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure Lancet 343 1994 1519 1522
22. D.C. Throckmorton, A.P. Brogden, B. Min, H. Rasmussen, and M. Kashgarian PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products Kidney Int 48 1995 111 117
23. M.E. Cooper Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease Am J Hypertens 17 2004 31S 38S
24. G.K. Reddy AGE-related cross-linking of collagen is associated with aortic wall matrix stiffness in the pathogenesis of drug-induced diabetes in rats Microvasc Res 68 2004 132 142
25. Z.S. Galis, and J.J. Khatri Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly Circ Res 90 2002 251 262
26. A.C. Newby Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates Cardiovasc Res 69 2006 614 624
27. C.P. Sodhi, Y.S. Kanwar, and A. Sahai Hypoxia and high glucose upregulate AT1 receptor expression and potentiate ANG II-induced proliferation in VSM cells Am J Physiol Heart Circ Physiol 284 2003 H846 H852
28. E.N. Lavrentyev, A.M. Estes, and K.U. Malik Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells Circ Res 101 2007 455 464
29. D.J. Leehey, A.K. Singh, N. Alavi, and R. Singh Role of angiotensin II in diabetic nephropathy Kidney Int Suppl 77 2000 S93 S98
30. S.M. Twigg, M.M. Chen, A.H. Joly, S.D. Chakrapani, J. Tsubaki, and H.S. Kim Advanced glycosylation end products up-regulate connective tissue growth factor (insulin-like growth factor-binding protein-related protein 2) in human fibroblasts: a potential mechanism for expansion of extracellular matrix in diabetes mellitus Endocrinology 142 2001 1760 1769
31. A.A. Eddy Interstitial fibrosis in hypercholesterolemic rats: role of oxidation, matrix synthesis, and proteolytic cascades Kidney Int 53 1998 1182 1189
32. A.A. Eddy Interstitial inflammation and fibrosis in rats with diet-induced hypercholesterolemia Kidney Int 50 1996 1139 1149
33. A.R. Chade, O.P. Mushin, X. Zhu, M. Rodriguez-Porcel, J.P. Grande, and S.C. Textor Pathways of renal fibrosis and modulation of matrix turnover in experimental hypercholesterolemia Hypertension 46 2005 772 779
34. A.R. Chade, M. Rodriguez-Porcel, S.J. Rippentrop, A. Lerman, and L.O. Lerman Angiotensin II AT1 receptor blockade improves renal perfusion in hypercholesterolemia Am J Hypertens 16 2003 111 115
35. A.R. Chade, M.D. Bentley, X. Zhu, M. Rodriguez-Porcel, S. Niemeyer, and B. Amores-Arriaga Antioxidant intervention prevents renal neovascularization in hypercholesterolemic pigs J Am Soc Nephrol 15 2004 1816 1825
36. A.R. Chade, M. Rodriguez-Porcel, J.P. Grande, J.D. Krier, A. Lerman, and J.C. Romero Distinct renal injury in early atherosclerosis and renovascular disease Circulation 106 2002 1165 1171
37. G. Ding, H. van Goor, S.D. Ricardo, J.M. Orlowski, and J.R. Diamond Oxidized LDL stimulates the expression of TGF-beta and fibronectin in human glomerular epithelial cells Kidney Int 51 1997 147 154
38. C.Y. Song, B.C. Kim, H.K. Hong, and H.S. Lee Oxidized LDL activates PAI-1 transcription through autocrine activation of TGF-beta signaling in mesangial cells Kidney Int 67 2005 1743 1752
39. M. Kumar, N. Tyagi, K.S. Moshal, U. Sen, S.B. Pushpakumar, and T. Vacek GABAA receptor agonist mitigates homocysteine-induced cerebrovascular remodeling in knockout mice Brain Res 1221 2008 147 153
40. K.S. McCully Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis Am J Pathol 56 1969 111 128
41. Y.H. Guo, F.Y. Chen, G.S. Wang, L. Chen, and W. Gao Diet-induced hyperhomocysteinemia exacerbates vascular reverse remodeling of balloon-injured arteries in rat Chin Med J (Engl) 121 2008 2265 2271
42. J.C. Tsai, H. Wang, M.A. Perrella, M. Yoshizumi, N.E. Sibinga, and L.C. Tan Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells J Clin Invest 97 1996 146 153
43. L.M. Rasmussen, P.R. Hansen, and T. Ledet Homocysteine and the production of collagens, proliferation and apoptosis in human arterial smooth muscle cells APMIS 112 2004 598 604
44. O. Nygard, J.E. Nordrehaug, H. Refsum, P.M. Ueland, M. Farstad, and S.E. Vollset Plasma homocysteine levels and mortality in patients with coronary artery disease N Engl J Med 337 1997 230 236
45. H. Tan, X. Jiang, F. Yang, Z. Li, D. Liao, and J. Trial Hyperhomocysteinemia inhibits post-injury reendothelialization in mice Cardiovasc Res 69 2006 253 262
46. H. Kumagai, S. Katoh, K. Hirosawa, M. Kimura, A. Hishida, and N. Ikegaya Renal tubulointerstitial injury in weanling rats with hyperhomocysteinemia Kidney Int 62 2002 1219 1228
47. C. Noll, L. Raaf, C. Planque, L. Benard, L. Secardin, and E. Petit Protection and reversal of hepatic fibrosis by red wine polyphenols in hyperhomocysteinemic mice J Nutr Biochem 2010
48. A.V. Ovechkin, N. Tyagi, U. Sen, D. Lominadze, M.M. Steed, and K.S. Moshal 3-Deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic mice Am J Physiol Lung Cell Mol Physiol 291 2006 L905 L911
49. G. Doronzo, I. Russo, L. Mattiello, M. Trovati, and G. Anfossi Homocysteine rapidly increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. Role of phosphatidyl inositol 3-kinase and mitogen activated protein kinase pathways Thromb Haemost 94 2005 1285 1293
50. K. Robert, J. Nehme, E. Bourdon, G. Pivert, B. Friguet, and C. Delcayre Cystathionine beta synthase deficiency promotes oxidative stress, fibrosis, and steatosis in mice liver Gastroenterology 128 2005 1405 1415
51. J. Hamelet, K. Demuth, J. Dairou, A. Ledru, J.L. Paul, and J.M. Dupret Effects of catechin on homocysteine metabolism in hyperhomocysteinemic mice Biochem Biophys Res Commun 355 2007 221 227
52. A.D. Watson, J.A. Berliner, S.Y. Hama, B.N. La Du, K.F. Faull, and A.M. Fogelman Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein J Clin Invest 96 1995 2882 2891
53. P.N. Durrington, B. Mackness, and M.I. Mackness Paraoxonase and atherosclerosis Arterioscler Thromb Vasc Biol 21 2001 473 480
54. M. Nagase, K. Ando, T. Nagase, S. Kaname, T. Sawamura, and T. Fujita Redox-sensitive regulation of lox-1 gene expression in vascular endothelium Biochem Biophys Res Commun 281 2001 720 725
55. C. Noll, J. Hamelet, E. Matulewicz, J.L. Paul, J.M. Delabar, and N. Janel Effects of red wine polyphenolic compounds on paraoxonase-1 and lectin-like oxidized low-density lipoprotein receptor-1 in hyperhomocysteinemic mice J Nutr Biochem 20 2009 586 596
56. K.B. Holven, H. Scholz, B. Halvorsen, P. Aukrust, L. Ose, and M.S. Nenseter Hyperhomocysteinemic subjects have enhanced expression of lectin-like oxidized LDL receptor-1 in mononuclear cells J Nutr 133 2003 3588 3591
57. Y. Sun The renin-angiotensin-aldosterone system and vascular remodeling Congest Heart Fail 8 2002 11 16
58. M. Ruiz-Ortega, O. Lorenzo, M. Ruperez, V. Esteban, Y. Suzuki, and S. Mezzano Role of the renin-angiotensin system in vascular diseases: expanding the field Hypertension 38 2001 1382 1387
59. L. Hunyady, and K.J. Catt Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II Mol Endocrinol 20 2006 953 970
60. H. Suzuki, E.D. Motley, G.D. Frank, H. Utsunomiya, and S. Eguchi Recent progress in signal transduction research of the angiotensin II type-1 receptor: protein kinases, vascular dysfunction and structural requirement Curr Med Chem Cardiovasc Hematol Agents 3 2005 305 322
61. S. Eguchi, K. Numaguchi, H. Iwasaki, T. Matsumoto, T. Yamakawa, and H. Utsunomiya Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells J Biol Chem 273 1998 8890 8896
62. M. Ushio-Fukai, K.K. Griendling, P.L. Becker, L. Hilenski, S. Halleran, and R.W. Alexander Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells Arterioscler Thromb Vasc Biol 21 2001 489 495
63. S. Heeneman, J. Haendeler, Y. Saito, M. Ishida, and B.C. Berk Angiotensin II induces transactivation of two different populations of the platelet-derived growth factor beta receptor. Key role for the p66 adaptor protein Shc J Biol Chem 275 2000 15926 15932
64. F. Folli, C.R. Kahn, H. Hansen, J.L. Bouchie, and E.P. Feener Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk J Clin Invest 100 1997 2158 2169
65. R. Natarajan, S. Scott, W. Bai, K.K. Yerneni, and J. Nadler Angiotensin II signaling in vascular smooth muscle cells under high glucose conditions Hypertension 33 1999 378 384
66. W.A. Border, and N.A. Noble Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis Hypertension 31 1998 181 188
67. G. Wolf Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway Kidney Int 70 2006 1914 1919
68. J. Rodriguez-Vita, E. Sanchez-Lopez, V. Esteban, M. Ruperez, J. Egido, and M. Ruiz-Ortega Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism Circulation 111 2005 2509 2517
69. F. Yang, A.C. Chung, X.R. Huang, and H.Y. Lan Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3 Hypertension 54 2009 877 884
70. C.G. Brilla, G. Zhou, L. Matsubara, and K.T. Weber Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone J Mol Cell Cardiol 26 1994 809 820
71. M. Epstein Aldosterone receptor blockade and the role of eplerenone: evolving perspectives Nephrol Dial Transplant 18 2003 1984 1992
72. M.E. Ullian, J.R. Schelling, and S.L. Linas Aldosterone enhances angiotensin II receptor binding and inositol phosphate responses Hypertension 20 1992 67 73
73. H. Hatakeyama, I. Miyamori, T. Fujita, Y. Takeda, R. Takeda, and H. Yamamoto Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells J Biol Chem 269 1994 24316 24320
74. V. Robert, C. Heymes, J.S. Silvestre, A. Sabri, B. Swynghedauw, and C. Delcayre Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis Hypertension 33 1999 981 986
75. F. Michel, M.L. Ambroisine, M. Duriez, C. Delcayre, B.I. Levy, and J.S. Silvestre Aldosterone enhances ischemia-induced neovascularization through angiotensin II-dependent pathway Circulation 109 2004 1933 1937
76. Y. Sun, J. Zhang, J.Q. Zhang, and F.J. Ramires Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats Hypertension 35 2000 1078 1084
77. N.J. Brown, S. Nakamura, L. Ma, I. Nakamura, E. Donnert, and M. Freeman Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo Kidney Int 58 2000 1219 1227
78. Y.S. Lee, J.A. Kim, K.L. Kim, H.S. Jang, J.M. Kim, and J.Y. Lee Aldosterone upregulates connective tissue growth factor gene expression via p38 MAPK pathway and mineralocorticoid receptor in ventricular myocytes J Korean Med Sci 19 2004 805 811
79. M.K. Rude, T.A. Duhaney, G.M. Kuster, S. Judge, J. Heo, and W.S. Colucci Aldosterone stimulates matrix metalloproteinases and reactive oxygen species in adult rat ventricular cardiomyocytes Hypertension 46 2005 555 561
80. J. Massague, S.W. Blain, and R.S. Lo TGFbeta signaling in growth control, cancer, and heritable disorders Cell 103 2000 295 309
81. R. Derynck, R.J. Akhurst, and A. Balmain TGF-beta signaling in tumor suppression and cancer progression Nat Genet 29 2001 117 129
82. R. Derynck, and X.H. Feng TGF-beta receptor signaling Biochim Biophys Acta 1333 1997 F105 F150
83. J. Massague, J. Seoane, and D. Wotton Smad transcription factors Genes Dev 19 2005 2783 2810
84. D. Javelaud, and A. Mauviel Mammalian transforming growth factor-betas: Smad signaling and physio-pathological roles Int J Biochem Cell Biol 36 2004 1161 1165
85. N.N. Singh, and D.P. Ramji The role of transforming growth factor-beta in atherosclerosis Cytokine Growth Factor Rev 17 2006 487 499
86. A. Nakao, K. Okumura, and H. Ogawa Smad7: a new key player in TGF-beta-associated disease Trends Mol Med 8 2002 361 363
87. M. Wang, D. Zhao, G. Spinetti, J. Zhang, L.Q. Jiang, and G. Pintus Matrix metalloproteinase 2 activation of transforming growth factor-beta1 (TGF-beta1) and TGF-beta1-type II receptor signaling within the aged arterial wall Arterioscler Thromb Vasc Biol 26 2006 1503 1509
88. H. Ikedo, K. Tamaki, S. Ueda, S. Kato, M. Fujii, and D.P. Ten Smad protein and TGF-beta signaling in vascular smooth muscle cells Int J Mol Med 11 2003 645 650
89. M. Ruiz-Ortega, J. Rodriguez-Vita, E. Sanchez-Lopez, G. Carvajal, and J. Egido TGF-beta signaling in vascular fibrosis Cardiovasc Res 74 2007 196 206
90. A. Bobik Transforming growth factor-betas and vascular disorders Arterioscler Thromb Vasc Biol 26 2006 1712 1720
91. F. Zhang, S. Tsai, K. Kato, D. Yamanouchi, C. Wang, and S. Rafii Transforming growth factor-beta promotes recruitment of bone marrow cells and bone marrow-derived mesenchymal stem cells through stimulation of MCP-1 production in vascular smooth muscle cells J Biol Chem 284 2009 17564 17574
92. A. Moustakas, and C.H. Heldin Non-Smad TGF-beta signals J Cell Sci 118 2005 3573 3584
93. A. Leask, and D.J. Abraham TGF-beta signaling and the fibrotic response FASEB J 18 2004 816 827
94. B. Perbal CCN proteins: multifunctional signalling regulators Lancet 363 2004 62 64
95. T. Hayashida, M. Decaestecker, and H.W. Schnaper Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells FASEB J 17 2003 1576 1578
96. R. Samarakoon, C.E. Higgins, S.P. Higgins, S.M. Kutz, and P.J. Higgins Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp 60(c-src)/MEK-dependent J Cell Physiol 204 2005 236 246
97. U. Seay, D. Sedding, S. Krick, M. Hecker, W. Seeger, and O. Eickelberg Transforming growth factor-beta-dependent growth inhibition in primary vascular smooth muscle cells is p38-dependent J Pharmacol Exp Ther 315 2005 1005 1012
98. M. Ruiz-Ortega, M. Ruperez, V. Esteban, and J. Egido Molecular mechanisms of angiotensin II-induced vascular injury Curr Hypertens Rep 5 2003 73 79
99. J.H. Li, X.R. Huang, H.J. Zhu, R. Johnson, and H.Y. Lan Role of TGF-beta signaling in extracellular matrix production under high glucose conditions Kidney Int 63 2003 2010 2019
100. R. Derynck, and Y.E. Zhang Smad-dependent and Smad-independent pathways in TGF-beta family signalling Nature 425 2003 577 584
101. A. Leask, A. Holmes, and D.J. Abraham Connective tissue growth factor: a new and important player in the pathogenesis of fibrosis Curr Rheumatol Rep 4 2002 136 142
102. L.F. Lau, and S.C. Lam The CCN family of angiogenic regulators: the integrin connection Exp Cell Res 248 1999 44 57
103. E. Gore-Hyer, D. Shegogue, M. Markiewicz, S. Lo, D. Hazen-Martin, and E.L. Greene TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells Am J Physiol Renal Physiol 283 2002 F707 F716
104. K. Hishikawa, T. Nakaki, and T. Fujii Transforming growth factor-beta(1) induces apoptosis via connective tissue growth factor in human aortic smooth muscle cells Eur J Pharmacol 385 1999 287 290
105. A. Leask, A. Holmes, C.M. Black, and D.J. Abraham Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts J Biol Chem 278 2003 13008 13015
106. A. Leask, and D.J. Abraham The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology Biochem Cell Biol 81 2003 355 363
107. W.H. Fan, and M.J. Karnovsky Increased MMP-2 expression in connective tissue growth factor over-expression vascular smooth muscle cells J Biol Chem 277 2002 9800 9805
108. J.K. Crean, D. Finlay, M. Murphy, C. Moss, C. Godson, and F. Martin The role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells J Biol Chem 277 2002 44187 44194
109. T. Ichii, H. Koyama, S. Tanaka, S. Kim, A. Shioi, and Y. Okuno Fibrillar collagen specifically regulates human vascular smooth muscle cell genes involved in cellular responses and the pericellular matrix environment Circ Res 88 2001 460 467
110. C. Amalinei, I.D. Caruntu, S.E. Giusca, and R.A. Balan Matrix metalloproteinases involvement in pathologic conditions Rom J Morphol Embryol 51 2010 215 228
111. S.K. Moon, B.Y. Cha, and C.H. Kim ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: Involvement of the ras dependent pathway J Cell Physiol 198 2004 417 427
112. J.R. Sheu, T.H. Fong, C.M. Liu, M.Y. Shen, T.L. Chen, and Y. Chang Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies Br J Pharmacol 143 2004 193 201
113. U. Schonbeck, F. Mach, G.K. Sukhova, C. Murphy, J.Y. Bonnefoy, and R.P. Fabunmi Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? Circ Res 81 1997 448 454
114. A. Mauviel Cytokine regulation of metalloproteinase gene expression J Cell Biochem 53 1993 288 295
115. H. Nagase, R. Visse, and G. Murphy Structure and function of matrix metalloproteinases and TIMPs Cardiovasc Res 69 2006 562 573
116. J. Wei, S. Bhattacharyya, and J. Varga Peroxisome proliferator-activated receptor gamma: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosis Curr Opin Rheumatol 22 2010 671 676
117. A.K. Ghosh, S. Bhattacharyya, G. Lakos, S.J. Chen, Y. Mori, and J. Varga Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma Arthritis Rheum 50 2004 1305 1318
118. H.A. Burgess, L.E. Daugherty, T.H. Thatcher, H.F. Lakatos, D.M. Ray, and M. Redonnet PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis Am J Physiol Lung Cell Mol Physiol 288 2005 L1146 L1153
119. A.K. Ghosh, S. Bhattacharyya, J. Wei, S. Kim, Y. Barak, and Y. Mori Peroxisome proliferator-activated receptor-gamma abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator FASEB J 23 2009 2968 2977
120. E. Agabiti-Rosei, A.M. Heagerty, and D. Rizzoni Effects of antihypertensive treatment on small artery remodelling J Hypertens 27 2009 1107 1114
121. D. Rizzoni, E. Porteri, C. De Ciuceis, I. Sleiman, L. Rodella, and R. Rezzani Effect of treatment with candesartan or enalapril on subcutaneous small artery structure in hypertensive patients with noninsulin-dependent diabetes mellitus Hypertension 45 2005 659 665
122. L.F. Fried Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease Kidney Int 74 2008 571 576
123. F. Simko Statins: a perspective for left ventricular hypertrophy treatment Eur J Clin Invest 37 2007 681 691
124. L. Foggensteiner, S. Mulroy, and J. Firth Management of diabetic nephropathy J R Soc Med 94 2001 210 217
125. B. Lassegue, and K.K. Griendling NADPH oxidases: functions and pathologies in the vasculature Arterioscler Thromb Vasc Biol 30 2010 653 661